Evidence map›Paper›PMID 28736647›Full record

ArticleJournal of gastrointestinal oncology2017

An elderly man with remote history of metastatic melanoma now with localized pancreas cancer and new liver masses.

Neil Vasan, Maria Ignez Braghiroli, Alexander N Shoushtari, Richard Kinh Gian Do, Marcia Edelweiss, Ali Shamseddine, Walid Faraj, Deborah Mukherji, Ali Haydar, Ashwaq Olayan and 6 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of gastrointestinal oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Neil VasanMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Maria Ignez BraghiroliDivision of Oncology, Institute of Cancer of São Paulo, University of São Paulo, São Paulo, Brazil.
Alexander N ShoushtariMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Richard Kinh Gian DoMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Marcia EdelweissMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Ali ShamseddineWeill Cornell Medicine, New York, NY, USA.
Walid FarajAmerican University of Beirut, Beirut, Lebanon.
Deborah MukherjiAmerican University of Beirut, Beirut, Lebanon.
Ali HaydarAmerican University of Beirut, Beirut, Lebanon.
Ashwaq OlayanNational Guard Hospital, Riyadh, Kingdom of Saudi Arabia.
Fouad SabatinNational Guard Hospital, Riyadh, Kingdom of Saudi Arabia.
Rita AssiAmerican University of Beirut, Beirut, Lebanon.
Imane El DikaAmerican University of Beirut, Beirut, Lebanon.
Leonard B SaltzMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Ghassan K Abou-AlfaMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Eileen M O'ReillyMemorial Sloan Kettering Cancer Center, New York, NY, USA.

Funding

Investigational Cancer Therapeutics Training Program (ICTTP)T32CA009207 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Omar Abdel-Wahab, Alexander Drilon · 1985 to 2026
$13.7M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28736647
PMCPMC5506282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.